SRR1323807
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1464411 | GTEX | — | 0.962 |
| 2 | SRR1079168 | GTEX | — | 0.933 |
| 3 | SRR1470035 | GTEX | — | 0.924 |
| 4 | SRR1315994 | GTEX | — | 0.917 |
| 5 | SRR1073755 | GTEX | — | 0.910 |
| 6 | SRR1468403 | GTEX | — | 0.905 |
| 7 | SRR1387989 | GTEX | — | 0.905 |
| 8 | SRR1441701 | GTEX | — | 0.904 |
| 9 | SRR1323603 | GTEX | — | 0.900 |
| 10 | SRR661925 | GTEX | — | 0.899 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 28 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.470 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.453 | Idelalisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.431 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.415 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.409 | Idelalisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.336 | Idelalisib | — uncovered |
| COMPLEMENT | 0.324 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.309 | Remibrutinib | — uncovered |
| COAGULATION | 0.289 | Binimetinib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.276 | Remibrutinib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.246 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.240 | Inavolisib | — uncovered |
| KRAS_SIGNALING_UP | 0.237 | Inavolisib | — uncovered |
| APOPTOSIS | 0.210 | Idelalisib | — uncovered |
| BILE_ACID_METABOLISM | 0.175 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.173 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.098 | Inavolisib | — uncovered |
| APICAL_SURFACE | 0.084 | Temsirolimus | — uncovered |
| HEME_METABOLISM | 0.074 | Temsirolimus | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.070 | Idelalisib | — uncovered |